Lung Cancer News and Research

Latest Lung Cancer News and Research

Cancer rates have decreased in men and remained stable in women

Data newly compiled by the American Cancer Society finds death rates for most major cancers continue to decline, but a growing and aging population continues to produce a rise in the total number of cancer deaths.

14 Apr 2004

The amount of female smokers rose by 600% in the 20th century

American women who smoke rose dramatically during the 20th century, resulting in a 600 percent increase by the year 2003 in the number of women who died of lung cancer. In the same period, the number of lung cancer deaths in men declined.

14 Apr 2004

Lung cancer affects male and females differently

An article in the April 14 issue of The Journal of the American Medical Association (JAMA) reviews current information on the "epidemic" of lung cancer in U.S. women, and explores contributing factors and possible reasons for increased lung cancer deaths in women.

13 Apr 2004

Overall rise in lung cancer and death in women

In the past fifty years, there has been a 600 percent increase in the number of women who will be diagnosed with lung cancer and die of the disease. However, the death rate for men has decreased slightly over the same period.

13 Apr 2004

New research into Human Papilloma Virus (HPV) and Cervical Cancer

Cervical cancer is the second-most prevalent cancer in women and, despite encouraging improvements in screening leading to earlier detection, cervical cancer still kills many women every year. The risk of cervical cancer is increased by infection with certain types of human papilloma virus (HPV).

12 Apr 2004

Vitamin E appears to cut in half people's risk of bladder cancer

Getting plenty of vitamin E by eating foods like nuts and olive oil appears to cut in half people's risk of bladder cancer, the fourth leading cancer killer among men, a new study suggests.

12 Apr 2004

Research shows that intense high dose cholesterol lowering drugs result in a major reduction in deaths and severe heart attacks

If you want to increase your chances of living longer, taking cholesterol drugs is an easy way to do it. That's the message from a Harvard study of 4,162 people hospitalized in 350 places in eight countries. It is the first research to show that intense lowering of cholesterol results in a major reduction in deaths and severe heart attacks.

7 Apr 2004

British Asian cancer patients are not being met because of a lack of consideration for cultural differences

The study, carried out in Leicester, looked at the information preferences of British Asian patients – the majority of which were first generation and spoke English as well as their native language. It found that over half of English-speaking Asian patients would prefer to discuss their cancer and read health leaflets in their mother tongue.

6 Apr 2004

Michigan opens new center to treat exposure to Vermiculite, Taconite, Asbestos

In response to the United States Environmental Protection Agency's (EPA) identification of major sources of public asbestos exposure in Michigan, the Barbara Ann Karmanos Cancer Institute and the Center for Occupational and Environmental Medicine (COEM) affiliated with Wayne State University (WSU) have joined forces to establish The National Center for Vermiculite and Asbestos-Related Cancers.

5 Apr 2004

Data on pre-clinical activity of satraplatin in prostate cancer to be released

Spectrum Pharmaceuticals, Inc has announced that new data on pre-clinical activity of satraplatin in prostate cancer cell lines are being presented at the 95th Annual Meeting of the American Association for Cancer Research (AACR) in Orlando, Florida.

29 Mar 2004

New Research Information on Tumor Necrosis Therapy

Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute’s Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People’s Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.

25 Mar 2004